熱門資訊> 正文

Guardant Health首席营销官辞职

2026-05-08 23:49

Guardant Health Chief Medical Officer Craig Eagle has resigned from the company, effective Friday.
An SEC filing did not indicate the reasons for his departure, nor who his replacement is.
Eagle previously served as vice president of medical affairs oncology at Roche (RHHBY) subsidiary Genentech. Before that, he had several leadership positions at Pfizer (PFE).
In April, it was announced Eagle joined OS Therapies' (OSTX) strategic advisory board.

More on Guardant Health

Guardant Health, Inc. (GH) Q1 2026 Earnings Call Transcript
Guardant Health, Inc. 2026 Q1 - Results - Earnings Call Presentation
Guardant Health: Leveraging Liquid Biopsy Testing Momentum
Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests
Guardant Health Non-GAAP EPS of -$0.45 beats by $0.02, revenue of $301.7M beats by $22.64M

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。